HEMERION
Live / Registered — Registered (as of 18 Feb 2025)
What this means for you
Registered since 18 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90554690
- Registration number
- 7697787
- Mark type
- Stylized text
- Filed
- 02 Mar 2021
- Published for opposition
- 30 Nov 2021
- Registered
- 18 Feb 2025
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical, medical and veterinary preparations for the prevention and treatment of cancer; Sanitary preparations for medical purposes; Pharmaceutical preparations for the diagnosis and treatment of oncological and inflammatory diseases and disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology
- Class 010 — Medical apparatus: (Based on 44(e)) Surgical and medical apparatus and instruments, namely, surgical instruments and apparatus, medical devices for detecting and treating cancer, x-ray apparatus and surgical apparatus and instruments for medical use; Medical imaging apparatus; Medical instruments for diagnosis and treatment of cancer; Lasers for surgical and medical use; Medical apparatus for the treatment of cancerous tumors; Radiological apparatus for medical purposes; Medical imaging apparatus for use in the field of oncology for diagnostic purposes; Radiotherapy apparatus; Medical diagnostic apparatus for detecting or testing cancer; Implantable subcutaneous drug delivery apparatus, specifically, implantable drug delivery ports and implantable drug delivery pumps; fluid injectors for medical purposes; probes for medical purposes
- Class 042 — Scientific and technological services: (Based on 44(e)) Scientific research for medical and surgical purposes in the field of cancerous diseases; Pharmaceutical research and development; Scientific and medical research in the field of lasers; Scientific research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; Conducting clinical trials as pharmaceutical research for others in the pharmaceutical field; Conduction preclinical trials as pharmaceutical research for others in the pharmaceutical field; in-vitro testing services, specifically, in vitro pharmaceutical testing being pharmaceutical research in the pharmaceutical field; scientific studies and research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; medical, pharmacological, biological and chemical studies and research all being scientific research for surgical and medical purposes in the field of cancerous diseases; pharmaceutical research and development of new medical devices and pharmaceutical products; pharmaceutical research services, namely, performance of biological, chemical and pharmacological analyses of pharmaceutical products
Owner
- HEMERION THERAPEUTICS, Villeneuve-d'Ascq, FR
- HEMERION THERAPEUTICS, Villeneuve-d'Ascq, FR
- HEMERION THERAPEUTICS, Villeneuve-d'Ascq, FR
Prosecution history
- 18 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 28 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jan 2025 — ASSIGNED TO EXAMINER
- 11 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jul 2024 — USE AMENDMENT FILED
- 11 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 23 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jan 2024 — SOU EXTENSION 4 GRANTED
- 19 Jan 2024 — SOU EXTENSION 4 FILED
- 19 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2023 — SOU EXTENSION 3 GRANTED